Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: The Origgio study

Autoimmunity Reviews

Volumn 13, Issue 6, 2014, Pages 609-614

  Monti, Giuseppe ^a   Saccardo, Francesco ^a   Castelnovo, Laura ^a   Novati, Paola ^a   Sollima, Salvatore ^b   Riva, Agostino ^b   Sarzi Puttini, Piercarlo ^b   Quartuccio, Luca ^c   De Vita, Salvatore ^c   Galli, Massimo ^b  

^a Ospedale di Saronno   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Chronic hepatitis C infection; Cryoglobulins; Mixed cryoglobulinaemia syndrome

Indexed keywords

CRYOGLOBULIN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED CRYOGLOBULINEMIA SYNDROME; PREVALENCE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; YOUNG ADULT;

CHRONIC HEPATITIS C INFECTION; CRYOGLOBULINS; MIXED CRYOGLOBULINAEMIA SYNDROME;

CRYOGLOBULINEMIA; CRYOGLOBULINS; HUMANS; ITALY; PREVALENCE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84896543838     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.11.005     Document Type: Review

References (56)

1. Landau D.A., Saadoun D., Calabrese L.H., Cacoub P. The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun Rev 2007, 6:581-587.
2. Lospalluto J., Dorward B., Miller W., Ziff M. Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin. Am J Med 1962, 32:142-147.
3. Invernizzi F., Galli M., Serino G., Monti G., Meroni P.L., Granatieri C., et al. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 1983, 70:73-82.
4. Visentini M., Conti V., Cristofoletti C., Lazzeri C., Marrapodi R., Russo G., et al. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev 2013, 12:430-435.
5. Giuggioli D., Manfredi A., Colaci M., Manzini C.U., Antonelli A., Ferri C. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. Autoimmun Rev 2013, 12:1058-1063.
6. Meltzer M., Franklin E.C. Cryoglobulinemia - a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966, 40:828-836.
7. Monti G., Galli M., Invernizzi F., et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 1995, 88:115-126.
8. Saadoun D., Landau D.A., Calabrese L.H., Cacoub P.P. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford) 2007, 46:1234-1242.
9. Della Rossa A., Marchi F., Catarsi E., Tavoni A., Bombardieri S. Mixed cryoglobulinemia and mortality: a review of the literature. Clin Exp Rheumatol 2008, 26(Suppl. 51):S105-S108.
10. Pascual M., Perrin L., Giostra E., Schifferli J.A. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990, 162:569-570.
11. Ferri C., Greco F., Longombardo G., et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991, 9:621-624.
12. Ferri C., Cacoub P., Mazzaro C., Roccatello D., Scaini P., Sebastiani M., et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011, 11:48-55.
13. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008, 3:25.
14. Visentini M., Ludovisi S., Petrarca A., Pulvirenti F., Zaramella M., Monti M., et al. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Autoimmun Rev 2011, 10:714-719.
15. Pietrogrande M., De Vita S., Zignego A.L., Pioltelli P., Sansonno D., Sollima S., et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011, 10:444-454.
16. Galli M., Monti G., Monteverde A., Invernizzi F., Pietrogrande M., Di Girolamo M., et al. Hepatitis C virus and mixed cryoglobulinaemia. Lancet 1992, 339:989.
17. Kayali Z., Buckwold V.E., Zimmerman B., Schmidt W.N. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002, 36:978-985.
18. Adinolfi L.E., Utili R., Attanasio V., et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996, 28:1-12.
19. Ferri C., Sebastiani M., Giuggioli D., et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004, 33:355-374.
20. Giordano T.P., Henderson L., Landgren O., et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007, 297:2010-2017.
21. Lunel F., Musset L., Cacoub P., et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994, 106:1291-1300.
22. Charles E.D., Dustin L.B. Hepatitis C virus-induced cryoglobulinemia. Kidney Int 2009, 76:818-824.
23. Invernizzi F., Pietrogrande M., Sagramoso B. Classification of the cryoglobulinemic syndrome. Clin Exp Rheumatol 1995, 13(Suppl. 13):S123-S128.
24. Ferri C., Zignego A.L., Pileri S.A. Cryoglobulins. J Clin Pathol 2002, 55:4-13.
25. De Vita S., Soldano F., Isola M., et al. Preliminary classification criteria for the cryoglobulinemic syndrome. Ann Rheum Dis 2011, 70:1183-1190.
26. Yen T., Keeffe E.B., Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003, 36:47-53.
27. Mühlberger N., Schwarzer R., Lettmeier B., Sroczynski G., Zeuzem S., Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009, 9:34. 10.1186/1471.
28. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999, 6:35-47.
29. daCosta DiBonaventura M., Yuan Y., Wagner J.-S., L'Italien G.J., Lescrauwaet B., Langley P. The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes. Eur J Gastroenterol Hepatol 2012, 24:869-877.
30. Cornberg M., Razavi H.A., Alberti A., et al. A systematic review of hepatitis C virus epidemiology in Europe. Liver Int 2011, (Suppl. 2):30-60. 10.1111/j.
31. Decision No 1350/2007/EC of the European Parliament and of the Council, 23 October 2007. OJ L301, 20/11/2007, p. 3.
32. Faustini A., Colai P., Fabrizi E., et al. Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. BMC Infect Dis 2010, 10:97.
33. Ansaldi F., Bruzzone B., Salmaso S., et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 2005, 6:327-332.
34. Raffaele A., Valenti M., Iovenitti M., et al. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol 2001, 17:41-46.
35. Cozzolongo R., Osella A.R., Elba S., et al. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol 2009, 104:2740-2746.
36. Campello C., Poli A., Dal M.G., Besozzi-Valentini F. Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Infection 2002, 30:7-12.
37. Fabris P., Baldo V., Baldovin T., et al. Changing epidemiology of HCV and HBV infections in Northern Italy. A survey in the general population. J Clin Gastroenterol 2008, 42:527-532.
38. Maggi G., Armitano S., Brambilla L., et al. Hepatitis C infection in an Italian population not selected for risk factors. Liver 1999, 19:427-431.
39. Tibbs C.J. Methods of transmission of hepatitis C. J Virol Hepatol 1995, 2:113-119.
40. Mariano A., Tosti M.E., Spada E., Mele A. Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy. Scand J Infect Dis 2009, 41:689-699.
41. La Torre G., Gualano M.R., Semyonov L., Nicolotti N., Ricciardi W., Boccia A. Hepatitis C virus infection trends in Italy, 1996-2006. Hepat Mon 2011, 895-900.
42. Brouet J.P., Clauvel J.C., Danon F., et al. Biological and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974, 57:775-788.
43. Pawlotsky J.M., Ben Yahia M., Andre C., et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841-848.
44. De Re V., De Vita S., Sansonno D., et al. Type II mixed cryoglobulinemia as an oligo rather than mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology 2006, 45:685-693.
45. De Re V., Caggiari L., De Vita S., et al. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig Liver Dis 2007, 39(Suppl. 1):S65-S71.
46. Giannini C., Gragnani L., Piluso A., et al. Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?. Blood 2008, 112:4353-4354.
47. Gragnani L., Piluso A., Giannini C., et al. Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors. Arthritis Rheum 2011, 63:1446-1451.
48. Garcia-Carrasco M., Ramos-Casals M., Cervera R., et al. Cryoglobulinaemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients. Semin Arthritis Rheum 2001, 30:366-373.
49. Casato M., Lilli D., Donato G., et al. Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat 2003, 10:455-459.
50. Ferri C., Mascia T. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006, 18:54-63.
51. Galli M., GISC Cryoglobulinaemia and serological markers of hepatitis viruses. Lancet 1991, 338:758-759.
52. Velati C., Romanò L., Fomiatti L., Baruffi L., Zanetti A.R., SIMTI Research Group Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008, 48:2205-2213.
53. Raimondo G., Navarra G., Mondello S., et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008, 48:743-746.
54. Raimondo G., Pollicino T., Romanò L., Zanetti A.R. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris) 2010, 58:254-257.
55. De Marco L., Gillio-Tos A., Fiano V., et al. Occult HCV infection: an unexpected finding in a population unselected for hepatic disease. PLoS One 2009, 4:e8128.
56. Quartuccio L., Isola M., Corazza L., et al. Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol 2012, 30(1 Suppl. 70):S48-S52.